France Steps Up Scrutiny Of Epilepsy Drug Risks In Pregnancy
Executive Summary
The French health authorities are looking more widely at the actual or potential risks of using anti-epileptic medicines in pregnancy or in women of child bearing age. Valproate is a particular focus, but other drugs like topiramate and pregabalin are also in the frame.
You may also be interested in...
EMA Calls For Visual Warnings Among Measures To Restrict Valproate Use
The European Medicines Agency has recommended that EU member states should introduce further restrictions on the use of valproate-containing medicines to avoid the drug's exposure in pregnancy.
Industry & Regulators To Align Advice on COVID-19 Vaccine Updates
A multi-stakeholder workshop looked at the data needed to support updates to vaccine composition and the time required by manufacturers to update their vaccines, change their manufacturing processes and prepare approval applications.
Denmark Planning To Impose Drug Stockpiling Obligations From July
A new bill is intended to address the increase in medicine supply problems in Denmark in recent years.